News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,529 Results
Type
Article (28258)
Company Profile (189)
Press Release (668067)
Multimedia
Podcasts (147)
Webinars (28)
Section
Business (229816)
Career Advice (1700)
Deals (35257)
Drug Delivery (145)
Drug Development (74008)
Employer Resources (163)
FDA (15914)
Job Trends (13992)
News (335118)
Policy (30641)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (1446)
Accelerated approval (47)
ADA (38)
Adcomms (22)
Allergies (181)
Alliances (49254)
ALS (176)
Alzheimer's disease (1495)
Antibody-drug conjugate (ADC) (453)
Approvals (16497)
Artificial intelligence (695)
ASCO (245)
Autoimmune disease (328)
Automation (64)
Bankruptcy (337)
Best Places to Work (10641)
BIO (70)
BIOSECURE Act (21)
Biosimilars (246)
Biotechnology (124)
Bladder cancer (186)
Brain cancer (53)
Breast cancer (669)
Cancer (5393)
Cardiovascular disease (420)
Career advice (1460)
Career pathing (42)
CAR-T (338)
CDC (44)
Celiac Disease (1)
Cell therapy (945)
Cervical cancer (53)
Clinical research (65873)
Collaboration (2103)
Commercialization (3)
Company closure (3)
Compensation (1525)
Complete response letters (77)
COVID-19 (1881)
CRISPR (99)
C-suite (1212)
Cystic fibrosis (140)
Data (7919)
Decentralized trials (1)
Denatured (41)
Depression (158)
Dermatology (98)
Diabetes (607)
Diagnostics (6497)
Digital health (61)
Diversity (9)
Diversity, equity & inclusion (36)
Drug discovery (334)
Drug pricing (208)
Drug shortages (34)
Duchenne muscular dystrophy (281)
Earnings (91044)
Editorial (69)
Employer branding (19)
Employer resources (140)
Events (116968)
Executive appointments (1129)
FDA (19873)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (28)
Funding (1580)
Gene editing (215)
Generative AI (57)
Gene therapy (701)
GLP-1 (922)
Government (3674)
Grass and pollen (7)
Guidances (404)
Healthcare (15495)
Hematology (158)
HIV (79)
Huntington's disease (51)
IgA nephropathy (106)
Immunology and inflammation (235)
Immuno-oncology (92)
Indications (216)
Infectious disease (2205)
Inflammatory bowel disease (200)
Inflation Reduction Act (16)
Influenza (136)
Intellectual property (320)
Interviews (267)
IPO (16228)
IRA (52)
Job creations (3700)
Job search strategy (1235)
JPM (59)
Kidney cancer (21)
Labor market (102)
Layoffs (425)
Leadership (40)
Legal (7534)
Liver cancer (80)
Longevity (29)
Lung cancer (721)
Lymphoma (407)
Machine learning (56)
Management (55)
Manufacturing (1244)
Marketing (10)
MASH (183)
Medical affairs (1)
Medical device (13641)
Medtech (13819)
Mergers & acquisitions (20387)
Metabolic disorders (1456)
mRNA (193)
Multiple sclerosis (188)
NASH (9)
Neurodegenerative disease (390)
Neuropsychiatric disorders (81)
Neuroscience (2910)
Neurotech (1)
NextGen: Class of 2026 (5659)
Non-profit (2360)
Now hiring (50)
Obesity (639)
Opinion (318)
Ovarian cancer (209)
Pain (228)
Pancreatic cancer (314)
Parkinson's disease (341)
Partnered (33)
Patents (630)
Patient recruitment (693)
Peanut (62)
People (58469)
Pharmaceutical (47)
Pharmacy benefit managers (32)
Phase 1 (20627)
Phase 2 (28935)
Phase 3 (21378)
Pipeline (9726)
Policy (323)
Postmarket research (2275)
Preclinical (8630)
Press Release (68)
Prostate cancer (297)
Psychedelics (46)
Radiopharmaceuticals (344)
Rare diseases (1044)
Real estate (5755)
Recruiting (69)
Regulatory (24966)
Reports (47)
Research institute (1517)
Resumes & cover letters (259)
Rett syndrome (43)
RNA editing (23)
RSV (76)
Schizophrenia (162)
Series A (268)
Series B (204)
Service/supplier (6)
Sickle cell disease (103)
Special edition (22)
Spinal muscular atrophy (147)
Sponsored (41)
Startups (3433)
State (1)
Stomach cancer (7)
Supply chain (145)
Tariffs (95)
The Weekly (104)
Vaccines (893)
Venture capital (97)
Weight loss (418)
Women's health (124)
Worklife (21)
Date
Last 7 days (409)
Last 30 days (1673)
Last 365 days (28169)
2026 (16301)
2025 (28106)
2024 (32812)
2023 (37552)
2022 (48122)
2021 (52083)
2020 (49973)
2019 (41413)
2018 (31320)
2017 (30713)
2016 (29589)
2015 (35711)
2014 (29870)
2013 (25749)
2012 (28192)
2011 (28495)
2010 (26797)
Location
Africa (667)
Alabama (88)
Alaska (5)
Arizona (362)
Arkansas (14)
Asia (39497)
Australia (6195)
California (13702)
Canada (3780)
China (1417)
Colorado (581)
Connecticut (560)
Delaware (371)
Europe (80384)
Florida (2048)
Georgia (442)
Hawaii (4)
Idaho (61)
Illinois (1101)
India (98)
Indiana (620)
Iowa (22)
Japan (595)
Kansas (130)
Kentucky (44)
Louisiana (39)
Maine (88)
Maryland (1600)
Massachusetts (9693)
Michigan (403)
Minnesota (727)
Mississippi (7)
Missouri (160)
Montana (32)
Nebraska (27)
Nevada (153)
New Hampshire (88)
New Jersey (3610)
New Mexico (28)
New York (3475)
North Carolina (1734)
North Dakota (10)
Northern California (6977)
Ohio (408)
Oklahoma (23)
Oregon (35)
Pennsylvania (2581)
Puerto Rico (29)
Rhode Island (45)
South America (1058)
South Carolina (89)
South Dakota (1)
Southern California (5447)
Tennessee (201)
Texas (2198)
United States (47857)
Utah (416)
Vermont (2)
Virginia (338)
Washington D.C. (67)
Washington State (1080)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
696,529 Results for "zeus industrial products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zeus Launches PFX™ Platform and Introduces PFX Flex™ Sub-Lite-Wall™, Advancing the Future of Catheter Innovation
January 30, 2026
·
3 min read
Press Releases
IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production
June 1, 2026
·
3 min read
Business
Zeus Names Chief Technology Officer
Zeus, a world leader in polymer extrusion and catheter manufacturing, announces the appointment of Suresh Sainath as Chief Technology Officer.
April 22, 2024
·
2 min read
Press Releases
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
July 16, 2026
·
6 min read
Manufacturing
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
Top-selling cell therapies from BMS, J&J and Gilead depend on a BioLife product, positioning Repligen to use the takeover to increase its exposure to the modality.
July 22, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
July 2, 2026
·
6 min read
Press Releases
Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
February 26, 2026
·
4 min read
Press Releases
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Advancing efficiency and alignment in biologics development, through product-specific methods, to support broader availability of biologics, including biosimilars, for patients
June 1, 2026
·
4 min read
Press Releases
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
July 7, 2026
·
8 min read
Press Releases
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld
Ad hoc announcement pursuant to Art. 53 LR • The next phase of the greenfield project in Sisslerfeld (Eiken, Switzerland) will be implemented as part of a strategic collaboration. • Total investment amounts to more than CHF 500 million. • Start of commercial production at the new site is expected in 2030.
July 21, 2026
·
2 min read
1 of 69,653
Next
